Press Releases

NEW YORK, Oct. 31, 2019 /PRNewswire/ -- Hospital for Special Surgery (HSS), ranked No. 1 in the nation for Orthopedics for the past 10 consecutive years by US News & World Report, today announced the appointments of

PARIS, Oct. 31, 2019 /PRNewswire/ -- Sanofi (NASDAQ: SNY; EURONEXT: SAN) Q3 2019

HORSHAM, Pa., Oct. 31, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will be presenting results from 30 abstracts across the company's expanding rheumatology portfolio and pipeline products during the 2019 American College of Rheumatology (ACR)/Association for Rheumatology Health Professionals (ARHP) Annual Mee

SPRING, Texas, Oct. 31, 2019 /PRNewswire/ -- Today the Global Prebiotic Association (GPA), the worldwide resource for prebiotic education, insights and awareness building, announced the addition of five new members. Church & Dwight and Clasado joined GPA at the Member level and Fresenius Kabi, Iprona and Olipop have joined at the Associate Member level. A preb

COLLEGE PARK, Md., Oct. 31, 2019 /PRNewswire/ -- gel-e Inc., announces expansion of its' consumer products label to include antibacterial barrier capabilities while allowing for non-sterile manufacture of products with greater shelf- and use-life from the

NEW YORK, Oct. 31, 2019 /PRNewswire/ -- Klara (www.klara.com), the New York based leader in secure patient communication, is proud to announce a new partn

SAN DIEGO, Oct. 31, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the third quarter 2019, prior to the market open on Tue

SLOUGH, England and RICHMOND, Va., Oct. 31, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its Q3/YTD 2019 results press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at

COPENHAGEN, Denmark, Oct. 31, 2019 /PRNewswire/ -- CathVision ApS, a medical device company developing, manufacturing and selling cardiac electrophysiology products, has been awarded a competitive EU grant of 2.2M Euro for the clinical development of its software and clinical decision support platform. The EU grant is for an SME

NEW BRUNSWICK, N.J., Oct. 31, 2019 /PRNewswire/ -- The government of the Democratic Republic of the Congo (DRC) has decided to use the investigational Ebola vaccine regimen currently being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson as part of an expanded public health initiative to help contain the cou